PETQ - PetIQ, Inc.
NASDAQ
->
Healthcare
->
Drug Manufacturers—Specialty & Generic
Eagle,
United States
Type: Equity
PETQ price evolution
PETQ
| (in millions $) | 30 Jun 2024 | 31 Mar 2024 | 31 Dec 2023 | 30 Sep 2023 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $84.13 | $25.37 | $116.37 | $124.61 |
| Short term investments | ||||
| Net receivables | $214.98 | $191.86 | $142.51 | $151.68 |
| Inventory | $164.97 | $215.38 | $159.31 | $128.13 |
| Total current assets | $471.05 | $444.92 | $430.83 | $410.66 |
| Long term investments | ||||
| Property, plant & equipment | $70.65 | $73.4 | $76.18 | $75.22 |
| Goodwill & intangible assets | $351.02 | $354.9 | $359.13 | $368.84 |
| Total noncurrent assets | $423.35 | $430.32 | $437.39 | $446.43 |
| Total investments | ||||
| Total assets | $894.39 | $875.24 | $868.23 | $857.09 |
| Current liabilities | ||||
| Accounts payable | $142.23 | $137.86 | $139.26 | $113.45 |
| Deferred revenue | ||||
| Short long term debt | $12.79 | $14.73 | $16.2 | $14.98 |
| Total current liabilities | $182.68 | $184 | $189.53 | $164.64 |
| Long term debt | $447.8 | $449.79 | $452.1 | $448.61 |
| Total noncurrent liabilities | $451.4 | $453.39 | $455.7 | $453.28 |
| Total debt | $460.59 | $464.52 | $468.3 | $463.59 |
| Total liabilities | $634.08 | $637.39 | $645.23 | $617.92 |
| Shareholders' equity | ||||
| Retained earnings | -$130.37 | -$145.69 | -$160.6 | -$143.12 |
| Other shareholder equity | -$1.79 | -$1.71 | -$1.72 | |
| Total shareholder equity | $257.97 | $235.93 | $221.21 | $237.18 |
| (in millions $) | 31 Dec 2023 | 31 Jan 2023 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $116.37 | $101.27 | $79.41 | $33.46 |
| Short term investments | ||||
| Net receivables | $142.51 | $118 | $113.95 | $102.75 |
| Inventory | $159.31 | $142.6 | $96.44 | $97.77 |
| Total current assets | $430.83 | $370.11 | $298.69 | $242.3 |
| Long term investments | ||||
| Property, plant & equipment | $76.18 | $91.63 | $97.1 | $83.27 |
| Goodwill & intangible assets | $359.13 | $355.79 | $421.77 | $444.16 |
| Total noncurrent assets | $437.39 | $448.78 | $520.9 | $529.3 |
| Total investments | ||||
| Total assets | $868.23 | $818.9 | $819.59 | $771.59 |
| Current liabilities | ||||
| Accounts payable | $139.26 | $113 | $55.06 | $68.13 |
| Deferred revenue | ||||
| Short long term debt | $16.2 | $15.35 | $14.85 | $12.68 |
| Total current liabilities | $189.53 | $149.49 | $98.1 | $101.07 |
| Long term debt | $452.1 | $444.18 | $465.81 | $375.11 |
| Total noncurrent liabilities | $455.7 | $457.61 | $466.26 | $376.5 |
| Total debt | $468.3 | $471.93 | $480.66 | $387.78 |
| Total liabilities | $645.23 | $608.97 | $564.37 | $477.57 |
| Shareholders' equity | ||||
| Retained earnings | -$160.6 | -$162.73 | -$114.53 | -$93.38 |
| Other shareholder equity | -$1.71 | -$2.22 | -$0.68 | -$0.69 |
| Total shareholder equity | $221.21 | $209.92 | $252.83 | $262.41 |
| (in millions $) | 30 Jun 2024 | 31 Mar 2024 | 31 Dec 2023 | 30 Sep 2023 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $328.94 | $308.44 | $219.93 | $277.02 |
| Cost of revenue | $240.66 | $233.9 | $175.94 | $204.41 |
| Gross Profit | $88.28 | $74.54 | $43.99 | $72.61 |
| Operating activities | ||||
| Research & development | ||||
| Selling, general & administrative | $60.08 | $50.21 | $42.73 | $55.02 |
| Total operating expenses | $62.68 | $50.08 | $53.93 | $63.29 |
| Operating income | $25.61 | $24.46 | -$9.94 | $9.32 |
| Income from continuing operations | ||||
| EBIT | $25.46 | $24.34 | -$10.17 | $9.31 |
| Income tax expense | $0.89 | $0.33 | -$1.1 | $0.28 |
| Interest expense | $9.25 | $9.11 | $8.41 | $8.58 |
| Net income | ||||
| Net income | $15.32 | $14.91 | -$17.49 | $0.45 |
| Income (for common shares) | $15.32 | $14.91 | -$17.49 | $0.45 |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $1101.96 | $921.51 | $932.53 | $780.05 |
| Cost of revenue | $849.22 | $711.85 | $746.13 | $644.86 |
| Gross Profit | $252.74 | $209.66 | $186.39 | $135.19 |
| Operating activities | ||||
| Research & development | ||||
| Selling, general & administrative | $196.24 | $182.56 | $170.52 | $138.38 |
| Total operating expenses | $215.83 | $229.69 | $168.6 | $137.8 |
| Operating income | $36.91 | -$20.03 | $17.79 | -$2.62 |
| Income from continuing operations | ||||
| EBIT | $36.51 | -$19.62 | $12.6 | $1.04 |
| Income tax expense | -$0.17 | $1.21 | $3.87 | $52.22 |
| Interest expense | $34.55 | $27.37 | $24.7 | $26.3 |
| Net income | ||||
| Net income | $2.13 | -$48.21 | -$15.97 | -$77.47 |
| Income (for common shares) | $2.13 | -$48.21 | -$15.97 | -$77.47 |
| (in millions $) | 30 Jun 2024 | 31 Mar 2024 | 31 Dec 2023 | 30 Sep 2023 |
|---|---|---|---|---|
| Net income | $15.32 | $14.91 | -$17.49 | $0.45 |
| Operating activities | ||||
| Depreciation | $7.47 | $8.36 | $8.68 | $16.05 |
| Business acquisitions & disposals | $2.65 | |||
| Stock-based compensation | $2.79 | $2.61 | $1.41 | $2.85 |
| Total cash flows from operations | $57.88 | -$85.14 | -$2.84 | $50.33 |
| Investing activities | ||||
| Capital expenditures | -$1.67 | -$0.82 | -$2.94 | -$2.08 |
| Investments | ||||
| Total cash flows from investing | $0.98 | -$0.82 | -$2.94 | -$2.08 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | $2.3 | $0.05 | ||
| Net borrowings | -$2.1 | -$2.38 | -$2.26 | -$2.24 |
| Total cash flows from financing | $0.06 | -$5.07 | -$2.37 | -$2.25 |
| Effect of exchange rate | -$0.17 | $0.04 | -$0.1 | $0.18 |
| Change in cash and equivalents | $58.92 | -$91.04 | -$8.15 | $46 |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Net income | $2.13 | -$48.21 | -$15.97 | -$77.47 |
| Operating activities | ||||
| Depreciation | $44.5 | $35.47 | $39.3 | $30.98 |
| Business acquisitions & disposals | -$27.63 | -$96.07 | ||
| Stock-based compensation | $9.47 | $11.36 | $9.43 | $9.17 |
| Total cash flows from operations | $61.89 | $48.02 | $23.77 | -$4.6 |
| Investing activities | ||||
| Capital expenditures | -$9.14 | -$11.97 | -$26.14 | -$21.95 |
| Investments | ||||
| Total cash flows from investing | -$36.78 | -$11.97 | -$26.14 | -$118.02 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | $0.05 | -$3.74 | $13.43 | $9.27 |
| Net borrowings | -$9.09 | -$9.09 | $43.57 | $135.5 |
| Total cash flows from financing | -$10.19 | -$13.71 | $48.33 | $128.76 |
| Effect of exchange rate | $0.18 | -$0.48 | -$0.01 | $0.04 |
| Change in cash and equivalents | $14.92 | $22.34 | $45.96 | $6.14 |
News
Fundamentals
| Market cap | $924.97M |
|---|---|
| Enterprise value | $1.30B |
| Shares outstanding | 29.86M |
| Revenue | $1.13B |
|---|---|
| EBITDA | $89.51M |
| EBIT | $48.94M |
| Net Income | $13.19M |
| Revenue Q/Q | N/A |
| Revenue Y/Y | N/A |
| P/E ratio | 70.11 |
|---|---|
| EV/Sales | 1.15 |
| EV/EBITDA | 14.54 |
| EV/EBIT | 26.59 |
| P/S ratio | 0.82 |
| P/B ratio | 3.59 |
| Book/Share | 8.64 |
| Cash/Share | 2.82 |
| EPS | $0.44 |
|---|---|
| ROA | 1.51% |
| ROE | 5.54% |
| Debt/Equity | 2.92 |
|---|---|
| Net debt/EBITDA | 6.14 |
| Current ratio | 2.58 |
| Quick ratio | 1.68 |